Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms BSJ-04-060 |
Target |
Action degraders |
Mechanism CDK4 degraders(Cyclin-dependent kinase 4 degraders), CDK6 degraders(Cyclin-dependent kinase 6 degraders) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC37H37N9O6 |
InChIKeyHABSMJUGKHFHAY-UHFFFAOYSA-N |
CAS Registry2368951-03-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | United States | 29 Mar 2019 |